Key facts
- It has raised $12.8M; the latest was Seed Round ($9.3M) in Feb 2025.
- Notable investors include HV Capital Manager, 10x Founders, Acurio Ventures Partners, All Iron, Saarbruecker 21 — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Floy
- ·The full record, as it builds
Funding rounds
No funding rounds for Floy are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Floy
Developer of an artificial intelligence-driven technology designed to maximize the diagnostic value of routine imaging. The company's technology helps detect deadly diseases and abnormalities typically overlooked in medical images, enabling healthcare providers to get access to annual holistic health assessments to prevent diseases through early detection.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2021
- Employees
- 74
- Website
- floy.com/
- Ownership
- Privately Held (backing)
Floy doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Floy shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Floy in its N-PORT filings yet. We sweep new filings monthly.